Skip to main content
BFRG
NASDAQ Life Sciences

BullFrog AI Fails Nasdaq Equity Requirement Extension, Faces Delisting

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.588
Mkt Cap
$6.116M
52W Low
$0.425
52W High
$3.38
Market data snapshot near publication time

summarizeSummary

BullFrog AI Holdings, Inc. has failed to meet the terms of its Nasdaq extension for the minimum stockholders' equity requirement, putting its listing at severe risk. This follows an initial notice in August 2025 and an extension granted until February 2026. While the company intends to request a hearing, there is no guarantee of a further extension or successful compliance. Delisting would significantly impair the company's ability to raise capital and could lead to a material decline in stock price, posing a critical threat to its operational viability.


check_boxKey Events

  • Failed to Meet Nasdaq Extension Terms

    The company received notice from Nasdaq on February 19, 2026, that it had not met the terms of the extension granted to comply with the minimum $2,500,000 stockholders' equity requirement.

  • Subject to Delisting

    As a result of failing the extension terms, the company's securities are now subject to delisting from The Nasdaq Capital Market.

  • Intends to Request Hearing

    BullFrog AI plans to timely request a hearing before an independent Nasdaq Hearings Panel, which will automatically stay any suspension or delisting action pending the hearing.

  • Significant Risk of Delisting

    There is no assurance that the Panel will grant additional time or that the company will ultimately regain compliance, with delisting posing severe risks to liquidity and capital raising.


auto_awesomeAnalysis

BullFrog AI Holdings, Inc. has failed to meet the terms of its Nasdaq extension for the minimum stockholders' equity requirement, putting its listing at severe risk. This follows an initial notice in August 2025 and an extension granted until February 2026. While the company intends to request a hearing, there is no guarantee of a further extension or successful compliance. Delisting would significantly impair the company's ability to raise capital and could lead to a material decline in stock price, posing a critical threat to its operational viability.

在该文件披露时,BFRG的交易价格为$0.59,交易所为NASDAQ,所属行业为Life Sciences,市值约为$611.6万。 52周交易区间为$0.43至$3.38。 这份文件被评估为消极市场情绪,重要性评分为9/10。

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BFRG - Latest Insights

BFRG
Apr 13, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
9
BFRG
Apr 13, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
9
BFRG
Apr 01, 2026, 4:42 PM EDT
Filing Type: 424B5
Importance Score:
8
BFRG
Apr 01, 2026, 2:56 PM EDT
Filing Type: 8-K
Importance Score:
9
BFRG
Mar 30, 2026, 5:56 PM EDT
Filing Type: 8-K
Importance Score:
9
BFRG
Mar 30, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
BFRG
Mar 19, 2026, 4:45 PM EDT
Filing Type: 10-K
Importance Score:
9
BFRG
Feb 20, 2026, 8:28 PM EST
Filing Type: 8-K
Importance Score:
9
BFRG
Feb 17, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9